Non-invasive ventilation (NIV) in critical care
NIV · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Mask/hood inspiratory support ± EPAP for the cooperative patient: treats hypercapnic fatigue (especially COPD exacerbation with respiratory acidosis), hypoxaemia with high work of breathing, weaning, and avoids intubation in selected groups (immunosuppressed).
Red flags
- NIV must never delay inevitable intubation — failure to improve at 1–2 h is a decision point
- Vomiting, distension, falling GCS on NIV = stop and reassess
- Caution in severe hypoxaemic (de novo) respiratory failure — high failure rate; low threshold for intubation
Management
- Select: awake, cooperative, protecting airway, minimal secretions, no facial injury/vomiting
- COPD: start IPAP ~10–12/EPAP 4–5 cmH₂O, titrate IPAP to VT, RR and pH
- Cardiogenic pulmonary oedema: CPAP first-line; NIV if hypercapnic
- Review at 1–2 h with a gas: pH and RR improving = continue; worse or unchanged = do not persist — intubate
- Plan the ceiling of care BEFORE starting NIV out of hours
Exam pearls
- Strongest evidence: COPD with pH 7.25–7.35 (Brochard NEJM 1995) and immunosuppressed patients (Antonelli)
- A dedicated, experienced nurse at the bedside for the first hour doubles the chance of success
NIV is a monitored trial with an exit plan, not a destination.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.